ORIX Ventures Announces $10 Million Growth Capital Commitment to Talyst

  ORIX Ventures Announces $10 Million Growth Capital Commitment to Talyst

Funding Supports Growth of Market Leader in Pharmacy Automation and Operations

Business Wire

DALLAS -- November 07, 2012

ORIX Ventures announces the closing of a $10 million growth capital commitment
to Talyst. The funding is structured to provide immediate growth capital to
the company. Initial proceeds will be used to support Talyst’s expansion into
the long-term care and correctional markets, as well as its plans to achieve
greater penetration in acute-care market.

Located in Seattle, Washington, Talyst is a leader in pharmacy automation
providing enterprise-wide medication management across entire health systems.
Its solutions offer greater inventory control, enhanced workflow efficiency
and improved patient safety. Talyst was founded in 2002 to provide
easy-to-use, automated medication management systems to acute-care hospital
pharmacies.

The funding of Talyst underscores ORIX Ventures’ intent to forge partnerships
with fast-growing, later stage companies, as well as its particular interest
in health care companies.

“We believe this funding from ORIX Ventures validates the market leadership
and growth potential of Talyst,” said CEO Carla Corkern. “Having a strong
partner, such as ORIX Ventures, which can support the financial needs of
Talyst throughout our expansion gives us a competitive edge by enabling us to
respond quickly to marketplace opportunities.”

David Orlandella, a Principal at ORIX Ventures, commented, “We are pleased to
partner with Talyst’s management team which has demonstrated an impressive
ability to strategically scale the company and build a leading technology
company in the pharmacy automation space.”

About ORIX Ventures

ORIX Ventures provides customized financial solutions up to $50 million in
capital per transaction to mid- and late-stage companies which have
established customers and run-rate revenues of $10 million or greater. Since
its inception in 2001, ORIX Ventures has invested in more than 100 growth
companies throughout the U.S. and Canada. www.orixventures.com. ORIX USA is a
Dallas, Texas-based financial services and investment firm with more than
1,400 employees and primary offices in Dallas, New York, Los Angeles, Columbus
and Minneapolis. ORIX USA holds approximately $6 billion of assets and manages
through various subsidiaries an additional $25 billion. www.orix.com. ORIX USA
is a wholly owned subsidiary of ORIX Corporation, a Tokyo-based, publicly
owned international financial services company with operations in 27 countries
worldwide. ORIX Corporation is listed on the Tokyo (8591) and New York Stock
Exchanges (IX).

Follow us on Twitter: @orixventures

About Talyst

Talyst is a leader in pharmacy automation and engineers the safer pharmacy.
The company’s solutions provide enterprise-wide medication management across
entire health systems to offer greater inventory control, enhanced workflow
efficiency, and improved patient safety. As of 2012, Talyst has installed
automated systems in more than 600 integrated healthcare systems, acute-care
hospitals, long-term care facilities, and correctional institutions. Talyst
offers a powerful software platform with a suite of hardware components to
meet specific needs of health care providers. Visit Talyst at www.talyst.com.

Contact:

C. Pharr & Company for ORIX Ventures
Shelby Sabin Menczer, 214-763-6068
Shelby@pharrpr.com
 
Press spacebar to pause and continue. Press esc to stop.